Ovarian cancer prevention and screening – where do we stand today?

Authors

Cristina Bucur, Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaFollow
Irina Balescu, Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaFollow
Sorin Petrea, Carol Davila University, Ion Cantacuzino Clinical Hospital, Department of Surgery, Bucharest, RomaniaFollow
Bogdan Gaspar, Carol Davila University, Clinical Emergency Hospital of Bucharest, Department of Surgery, Bucharest, RomaniaFollow
Lucian Pop, Carol Davila University, Alessandrescu-Rusescu National Institute, Department of Obstetrics and Gynecology, Bucharest, RomaniaFollow
Valentin Varlas, Carol Davila University, Filantropia Clinical Hospital, Department of Obstetrics and Gynecology, Bucharest, RomaniaFollow
Adrian Hasegan, University of Sibiu, Faculty of Medicine, Sibiu Emergency Hospital, Department of Urology, Bucharest, RomaniaFollow
Marilena Stoian, Carol Davila University of Medicine and Pharmacy, Dr Ion Cantacuzino Hospital, Department of Internal Medicine, Bucharest, RomaniaFollow
Gabriel Petre Gorecki, Titu Maiorescu University, Faculty of Medicine, CF 2 Clinical Hospital, Department of Anesthesia and Intensive Care, Bucharest, RomaniaFollow
Nicolae Bacalbasa, Carol Davila University, Fundeni Clinical Institute, Department of Visceral Surgery, Bucharest, RomaniaFollow

Abstract

Widely recognized as the most deathful gynecologic malignancy affecting women worldwide, ovarian cancer has reported a significant decline in terms of prevalence and incidence in the last decades. This fact has been especially explained by to the use of menopausal hormonal therapy and of oral contraceptives in association with genetic, oncologic and gynecologic counseling. The aim of the current review is to discuss about actual ovarian cancer prevention and screening tools. For this reason, we reviewed several data related to ovarian cancer, such as: incidence and risk factors, histopathological types (epithelial with high- and low-grade serous carcinomas, clear cell carcinoma, mucinous carcinoma, germ cells ovarian cancer tumors), as well as screening, diagnosis and prevention methods (ovulation disruption, surgical prevention, etc.). Although progress has been reported in the last decades in terms of early diagnosis and treatment of ovarian cancer, this malignancy still represents a significant health problem affecting women worldwide. However, it seems that the golden key for optimizing the long-term outcomes in such patients is represented by a better understanding of the complex pathogenesis of this disease.

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Recommended Citation

Bucur, Cristina; Balescu, Irina; Petrea, Sorin; Gaspar, Bogdan; Pop, Lucian; Varlas, Valentin; Hasegan, Adrian; Stoian, Marilena; Gorecki, Gabriel Petre; and Bacalbasa, Nicolae (2024) "Ovarian cancer prevention and screening – where do we stand today?," Journal of Mind and Medical Sciences: Vol. 11: Iss. 1, Article 13.
DOI: https://doi.org/10.22543/2392-7674.1464
Available at: https://scholar.valpo.edu/jmms/vol11/iss1/13